ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Zavegepant Receives Authorization to Proceed, Achieves First In Human Dosing
September 17, 2020Biohaven Pharmaceutical reported the U.S. Food and Drug Administration (FDA) has authorized the initiation of clinical trials for oral zavegepant (formerly BHV-3500) and the company has achieved first in human dosing in a Phase 1 trial designed to ...
Pharma Sources Insight January 2025
